Drug Screening Market

Report Code MD 3239
Published in May, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Drug Screening Market Size by Product (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)), Sample (Urine, Breath, Hair), Drug (Alcohol, Cannabis, Opioids), End User (Workplace, Hospital, Law) - Global Forecast to 2029

Overview

The size of global drug screening market in terms of revenue was estimated to be worth $9.1 billion in 2024 and is poised to reach $19.5 billion by 2029, growing at a CAGR of 16.6% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Some of the key factors such as the enforcement of stringent laws mandating drug & alcohol testing, the rising drug & alcohol consumption are driving the market. However, bans on alcohol consumption in Islamic countries may restrain the growth of this market to a certain extent.

Attractive Opportunities in the Drug Screening Market

NORTH AMERICA

Market growth in North America can be attributed to rising consumption of illicit drugs, the availability of government funding to curb drug abuse, laws supporting drug screening, and the growing availability of products and services for drugs-of-abuse testing

The growth of the drug screening market is driven by the growing drug & alcohol consumption and the enforcement of stringent laws mandating drug & alcohol testing.

Rising regulatory approvals for new product & service launches would offer lucrative growth opportunities for market players in the coming years.

North America dominates the drug screening market. This market is projected to reach USD 9.3 billion by 2029, at a CAGR of 16.4% during the forecast period.

The APAC market is projected to register the highest growth in the forecast period due to growing illicit consumption of drugs, the developing healthcare infrastructure, and the rising adoption of stringent regulatory guidelines for drug testing.

Global Drug Screening Market Dynamics

DRIVER: Growing drug and alcohol consumption

Drug abuse and alcohol consumption are growing worldwide. According to the World Drug Report 2023, in 2021, 1 in every 17 people aged 15–64 in the world had used a drug in the past 12 months. The number of users grew from 240 million in 2011 to 296 million in 2021 or 5.8% of the global population aged 15-64. This is a 23% increase, partly due to population growth. Other drugs like Cannabis the second most used drug, with an estimated 219 million users i.e. 4.3% of the global adult population in 2021. In 2021, according to the US Department of Transportation, National Highway Traffic Safety Administration (NHTSA), 13,384 people died in alcohol-impaired driving crashes, i.e. a 14% rise from last year. The expanding consumption of illicit drugs & alcohol will advance raise the development of drug screening products & services on the road, thereby driving the overall market growth.

RESTRAINT: Ban on alcohol consumption in several Islamic countries

Alcohol consumption is banned in Islamic countries such as Pakistan, Afghanistan, Bahrain, Libya, Iran, the UAE (Emirate of Sharjah), Kuwait, and Yemen. Alcohol consumption in these regions is a punishable offense, and offenders face harsh punishments. For instance, in Afghanistan, it is illegal to purchase alcohol. Similarly, very strict laws have been implemented in Iran against alcohol consumption. As per Article 265 of the new Islamic Penal Code implemented in 2013, drinking alcohol is punishable by 80 lashes, irrespective of the gender of the offender. Also, in some cases, the offender may be sentenced to death. Owing to religious reasons, strict punishments, and stringent regulations, alcohol consumption in many Islamic countries is very low. This is a major restraint for the growth of the drug & alcohol testing market, especially the breathalyzers market, in these countries.

 

OPPORTUNITY: Oral Fluid Testing

Oral fluid is a promising new matrix for drug abuse testing programs at the workplace, drug treatment facilities, and pain management facilities. It has significant applications in drug abuse testing for law enforcement. The Department of Transport (DOT) is one of the major end users of drug testing services in the US. Owing to the various advantages of oral fluid testing, the DOT considers including this technique for drug and alcohol testing.The major advantages of oral fluid testing are ease of collection, gender-neutral nature, fewer chances of sample adulteration/tampering, and no requirement for special collection facilities. However, for the rapid adoption of oral fluid testing, limitations such as inconsistent oral fluid and elution buffer volume, variable drug recoveries, and inadequate oral fluid immunoassay sensitivity and specificity need to be overcome. If this test is widely adopted, it is expected to replace urine, hair, and blood-based drug tests. This is a significant opportunity for the market players to capitalize on in the market.

CHALLENGE: Accuracy and specificity concerns related to breathalyzers

In certain cases, breathalyzers have offered incorrect results due to errors in distinguishing alcohol from other chemical compounds containing a methyl group structure. Few alcohol testing machines identify ethyl alcohol (found in alcoholic drinks) and any compound with a similar molecular structure. The human breath comprise over 100 compounds, and nearly 70 to 80% contain the methyl group structure; hence, there is a prospect of these chemicals being incorrectly detected as ethyl alcohol. For instance, the National Highway Traffic Safety Administration has found that diabetes is characterized by elevated breath acetone levels—one of the many substances that can be falsely identified as ethyl alcohol by some breath machines.Moreover, lip gloss, mouthwashes, dentures, paints, glue, thinners, cleaning solvents, foams used for hand hygiene, cigarettes, and even inhalers used for asthma can modify breathalyzer test results. Routine maintenance and recalibration of a breathalyzer by police officials are also vital. Failure to maintain, recalibrate, and test breathalyzers can result in other errors. Therefore, the error associated with some breath analyzers is held as a challenge to market growth.

Global Drug Screening Market Ecosystem Analysis

By end user, drug testing laboratories was the largest market for drug screening industry in 2023. On the basis of end user, the drug screening is divided into workplaces, criminal justice systems & law enforcement, drug treatment centers, pain management centers, schools & colleges, hospitals, individual users, drug testing laboratories, and other end users. In 2023, the drug testing laboratories testing segment accounted for the largest market due to increasing drug abuse cases & rising screening tests.

 

By sample type, urine sample is expected to dominate the drug screening industry in 2024.

Based on sample type, he drug screening market is segmented into urine, breath, oral fluid (saliva), hair, and other samples. Urine samples accounted for the largest share the market. However, the oral fluid samples segment is expected to register the highest CAGR during the forecast period. The high growth rate of this segment is largely due to the growing preference for oral fluid samples and their benefits, such as easy collection, no specific requirement for sample collection, and lower risk of sample adulteration.

By region, North America was the largest regional market for drug screening industry in 2023.

Based on region, the drug screening market is bifurcated into North America, Europe, the Asia Pacific, Latin America, Middle East & Africa. North America was the largest regional segment of the overall market with a share followed by Europe in 2023. The largest share of this is attributed due to the mounting consumption of illicit drugs, the accessibility of government funding to control drug abuse, and the presence of key players in this region.

North America Region Holds the Largest Share of the Drug Screening Market

Based on region, the drug screening market is bifurcated into North America, Europe, the Asia Pacific, Latin America, Middle East & Africa. North America was the largest regional segment of the overall market with a share followed by Europe in 2023. The largest share of this is attributed due to the mounting consumption of illicit drugs, the accessibility of government funding to control drug abuse, and the presence of key players in this region.

 
 

Recent Developments of Drug Screening Market industry

  • In February 2024, Veriteque (US) entered into an agreement with OraSure Technologies (US), to become a formal distributor of Veriteque’s SwabTek test kit products. Under the distribution agreement, OraSure will offer Veriteque’s SwabTek brand of presumptive field test kits as a complementary offering alongside their proprietary oral fluid screening products. In December 2023, Quest Diagnostics (US) launched its new confirmatory testing service for novel psychoactive substances (NPS). The new paneltests for 88 compounds, covers a broad typeof drug classes, such as designer benzodiazepines ,designer opioids, designer stimulants, fentanyl analogs, synthetic cannabinoids, and other illicit drug additives.
  • In August 2022, Labcorp (US) acquired RWJBarnabas Health outreach laboratory business (US). This relationship will offer patients and providers enhanced access to high-quality laboratory services and enhance the laboratory service offerings. In August 2021, Quest Diagnostics (US) and Select Health of South Carolina (US) entered into an agreement to expand Select Health’s laboratory network for its Medicaid and Medicare-Medicaid dual-eligible enrolees and to enhance access to diagnostics information services for members.

Key Market Players

KEY PLAYERS IN THE Drug Screening Market INCLUDE

  • Labcorp (US)
  • Quest Diagnostics (US)
  • Abbottv (US)
  • Thermo Fisher Scientific Inc. (US)
  • Alfa Scientific Designs Inc. (US)
  • OraSure Technologies Inc. (US)
  • Siemens Healthineers AG (Germany)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • MPD Inc. (US)
  • Shimadzu Corporation (Japan)
  • Lifeloc Technologies Inc. (US)
  • Drägerwerk AG & Co. KGaA (Germany)
  • Premier Biotech Inc. (US)
  • Omega Laboratories Inc. (US)
  • Psychemedics Corporation (US)
  • Clinical Reference Laboratory Inc. (US)
  • American Bio Medica Corporation (US)
  • ACM Global Laboratories (US)
  • CareHealth America Corp (US)
  • Sciteck Inc. (US)
  • Intoximeters Inc. (US)
  • AccuSourceHR Inc. (US)
  • Cordant Health Solutions (US)
  • Intoxalock (US)
  • Millennium Health (US)

Want to explore hidden markets that can drive new revenue in Drug Screening Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 $9.1 billion
Projected Revenue by 2029 $19.5 billion
Revenue Rate Poised to Grow at a CAGR of 16.6%
Market Driver Growing drug and alcohol consumption
Market Opportunity Oral Fluid Testing

 

 

Key Questions Addressed by the Report

What is the projected market revenue value of the global drug screening market?
The global drug screening market boasts a total revenue value of $19.5 billion by 2029.
What is the estimated growth rate (CAGR) of the global drug screening market?
The global drug screening market has an estimated compound annual growth rate (CAGR) of 16.6% and a revenue size in the region of $9.1 billion in 2024.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Drug Screening Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
42
RESEARCH METHODOLOGY
48
EXECUTIVE SUMMARY
63
PREMIUM INSIGHTS
68
MARKET OVERVIEW
71
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing consumption of illicit drugs and alcohol
    - Enforcement of stringent laws mandating drug and alcohol testing
    - Increasing number of regulatory approvals for drug screening products and services
    RESTRAINTS
    - Ban on alcohol consumption in Islamic countries
    - Prohibition on workplace drug testing
    OPPORTUNITIES
    - Popularity of oral fluid testing
    - Introduction of fingerprint-based drug testing at workplaces
    - High growth opportunities in emerging economies
    CHALLENGES
    - Accuracy and specificity concerns in breathalyzers
    - False positive and negative results in drug screening
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.4 INDUSTRY TRENDS
    INCREASING USE OF ORAL FLUID TESTING
    GROWING NEED FOR SUBSTANCE TESTING PANELS
    TECHNOLOGICAL ADVANCEMENTS
    RISING FOCUS ON EMPLOYEE WELLNESS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
  • 5.7 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Sweat patch testing
    - Alcohol ignition interlock device
    - Point-of-care testing
    COMPLEMENTARY TECHNOLOGIES
    - Artificial Intelligence and machine learning
    - Biosensors
  • 5.8 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF SUBSTITUTES
    THREAT OF NEW ENTRANTS
  • 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.10 TARIFF AND REGULATORY ANALYSIS
    TARIFF ANALYSIS
    - Tariff of chromatography instruments (HS code: 902720)
    REGULATORY ANALYSIS
    - North America
    - Europe
    - Asia Pacific
    - Australia and New Zealand
    - Latin America
    - Middle East & Africa
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
    INDICATIVE PRICING ANALYSIS
  • 5.12 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR DRUG SCREENING PRODUCTS
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.13 KEY CONFERENCES AND EVENTS IN 2024–2025
  • 5.14 CASE STUDY ANALYSIS
    LEADING RETAIL CHAIN TO SAVE USD 1 MILLION WITH INSTANT ORAL FLUID DRUG SCREENING SOLUTIONS
    PRE-EMPLOYMENT TESTING IN LONG-TERM CARE INDUSTRY
    USE OF HAIR TESTING AND URINALYSIS IN TRANSPORTATION INDUSTRY
    RANDOM TESTING IN MANUFACTURING AND AUTOMOTIVE INDUSTRIES
  • 5.15 REVENUE MODEL ANALYSIS
    SERVICE FEES
    PRODUCT SALES
    SERVICE PACKAGES
  • 5.16 END USER ANALYSIS
    UNMET NEEDS
    END USER EXPECTATIONS
  • 5.17 FUNDING LANDSCAPE
  • 5.18 TRADE ANALYSIS
DRUG SCREENING MARKET, BY PRODUCT & SERVICE
108
  • 6.1 INTRODUCTION
  • 6.2 DRUG SCREENING SERVICES
    LABORATORY TESTING SERVICES
    - Higher accuracy and better reliability to propel segment growth
    ON-SITE TESTING SERVICES
    - Increasing emphasis on workplace safety to drive market
  • 6.3 DRUG SCREENING PRODUCTS
    ANALYTICAL INSTRUMENTS
    - Analytical instruments market, by type
    - Analytical instruments market, by modality
    RAPID TESTING DEVICES
    - Urine testing devices
    - Oral fluid testing devices
    CONSUMABLES
    - Assay kits
    - Sample collection devices
    - Calibrators and controls
    - Other consumables
DRUG SCREENING MARKET, BY SAMPLE TYPE
162
  • 7.1 INTRODUCTION
  • 7.2 URINE SAMPLES
    EASE OF COLLECTION AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH
  • 7.3 BREATH SAMPLES
    RISING NUMBER OF DRIVING-UNDER-INFLUENCE CASES TO PROPEL MARKET GROWTH
  • 7.4 ORAL FLUID SAMPLES
    NON-INVASIVE SAMPLE COLLECTION AND LOW CHANCE OF ADULTERATION TO BOOST MARKET GROWTH
  • 7.5 HAIR SAMPLES
    DETAILED INSIGHTS INTO LONG-TERM DRUG USE TO SPUR MARKET GROWTH
  • 7.6 OTHER SAMPLES
DRUG SCREENING MARKET, BY DRUG TYPE
174
  • 8.1 INTRODUCTION
  • 8.2 CANNABIS
    INCREASING LEGALIZATION FOR MEDICAL AND RECREATIONAL PURPOSES TO DRIVE MARKET
  • 8.3 ALCOHOL
    RISING REGULATORY COMPLIANCE IN SAFETY-SENSITIVE INDUSTRIES TO DRIVE MARKET
  • 8.4 COCAINE
    ILLICIT NATURE AND ASSOCIATED HEALTH RISKS TO FUEL MARKET GROWTH
  • 8.5 OPIOIDS
    INCREASING CASES OF OPIOIDS ADDICTION TO AID MARKET GROWTH
  • 8.6 AMPHETAMINE AND METHAMPHETAMINE
    GROWING USE AMONG EDUCATION SERVICE EMPLOYEES TO AUGMENT MARKET GROWTH
  • 8.7 OTHER DRUGS
DRUG SCREENING MARKET, BY END USER
187
  • 9.1 INTRODUCTION
  • 9.2 DRUG TESTING LABORATORIES
    DRUG TESTING LABORATORIES TO COMMAND HIGHEST GROWTH RATE DURING STUDY PERIOD
  • 9.3 WORKPLACES
    INCREASED FOCUS ON RANDOM DRUG TESTING AT OFFICES TO FUEL MARKET GROWTH
  • 9.4 CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES
    GROWING GOVERNMENT FOCUS ON DRUG TESTING TO DRIVE MARKET
  • 9.5 HOSPITALS
    RISING DRUG ABUSE CASES TO AID MARKET GROWTH
  • 9.6 DRUG TREATMENT CENTERS
    GROWING GOVERNMENT SUPPORT AGAINST DRUG ABUSE TO DRIVE MARKET
  • 9.7 INDIVIDUAL USERS
    STRINGENT REGULATIONS AND PERSONAL SAFETY CONCERNS TO DRIVE MARKET
  • 9.8 PAIN MANAGEMENT CENTERS
    GROWING ABUSE OF PRESCRIPTION DRUGS TO DRIVE MARKET
  • 9.9 SCHOOLS AND COLLEGES
    RISING FOCUS ON DRUG ABUSE TESTING PROGRAMS TO SUPPORT MARKET GROWTH
  • 9.10 OTHER END USERS
DRUG SCREENING MARKET, BY REGION
208
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - US to dominate North American drug screening market during study period
    CANADA
    - Increasing drunk driving-related accidental deaths to support market growth
  • 10.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Increasing number of drug-related deaths to drive market
    FRANCE
    - Robust healthcare infrastructure and proactive approach toward public health to aid market growth
    UK
    - Increase in illicit drug consumption to augment market growth
    ITALY
    - Growing consumption of illegal psychoactive substances and drugs among minors to boost market growth
    SPAIN
    - Stringent government regulations and high consumption of alcohol to aid market growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    JAPAN
    - Stringent laws for drug abuse and increased government support to drive market
    CHINA
    - Increasing alcohol consumption and rising cases of drunk driving to fuel market growth
    INDIA
    - Increase in illicit drug users and improved healthcare infrastructure to support market growth
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - Growing emphasis on substance abuse prevention at workplaces to drive market
    MEXICO
    - Increasing government focus on controlling drug trafficking and substance abuse to propel market growth
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MIDDLE EAST & AFRICA: RECESSION IMPACT
    GCC COUNTRIES
    - Technological advancements in drug screening to drive market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
416
  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
    MARKET RANKING ANALYSIS
    - Laboratory Corporation of America Holdings
    - Quest Diagnostics
    - Abbott
  • 11.5 BRAND/PRODUCT COMPARISON
  • 11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Overall footprint
    - Product footprint
    - Service footprint
    - Sample type footprint
    - Drug type footprint
    - Regional footprint
  • 11.7 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
  • 11.8 VALUATION AND FINANCIAL METRICS
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT/SERVICE LAUNCHES AND DEVELOPMENTS
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
438
  • 12.1 KEY PLAYERS
    LABORATORY CORPORATION OF AMERICA HOLDINGS
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    QUEST DIAGNOSTICS
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    ABBOTT
    - Business overview
    - Products/Services/Solutions offered
    - MnM view
    ORASURE TECHNOLOGIES INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    ALFA SCIENTIFIC DESIGNS INC.
    - Business overview
    - Products/Services/Solutions offered
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    DRÄGERWERK AG & CO. KGAA
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    LIFELOC TECHNOLOGIES, INC.
    - Business overview
    - Products/Services/Solutions offered
    MPD INC.
    - Business overview
    - Products/Services/Solutions offered
    OMEGA LABORATORIES, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    PREMIER BIOTECH, INC.
    - Business overview
    - Products/Services/Solutions offered
    PSYCHEMEDICS CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    F. HOFFMANN-LA ROCHE LTD.
    - Business overview
    - Products/Services/Solutions offered
    SHIMADZU CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    SIEMENS HEALTHINEERS AG
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    AMERICAN BIO MEDICA CORPORATION
    ACM GLOBAL LABORATORIES
    CAREHEALTH AMERICA CORP.
    CLINICAL REFERENCE LABORATORY, INC.
    INTOXIMETERS
    SCITECK, INC.
    ACCUSOURCEHR, INC.
    CORDANT HEALTH SOLUTIONS
    INTOXALOCK
    MILLENNIUM HEALTH
    ADVACARE PHARMA
APPENDIX
496
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 DRUG SCREENING MARKET: STUDY ASSUMPTIONS
  • TABLE 2 DRUG SCREENING MARKET: RISK ASSESSMENT
  • TABLE 3 KEY PRODUCT AND SERVICE LAUNCHES FOR DRUG AND ALCOHOL TESTING, 2020–2022
  • TABLE 4 LIST OF REGULATORY AUTHORITIES FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES
  • TABLE 5 DRUG SCREENING MARKET: ROLE IN ECOSYSTEM
  • TABLE 6 DRUG SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • TABLE 8 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 9 TARIFF FOR CHROMATOGRAPHY INSTRUMENTS (HS CODE: 902720)
  • TABLE 10 US: DRUG AND ALCOHOL TESTING REGULATIONS
  • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
  • TABLE 17 DRUG SCREENING MARKET: LIST OF MAJOR PATENTS
  • TABLE 18 DRUG SCREENING MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS
  • TABLE 19 UNMET NEEDS IN DRUG SCREENING MARKET
  • TABLE 20 END USER EXPECTATIONS IN DRUG SCREENING MARKET
  • TABLE 21 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 22 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 23 DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 24 DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 25 DRUG SCREENING SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 26 DRUG SCREENING SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 27 LABORATORY TESTING SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 28 LABORATORY TESTING SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 29 ON-SITE TESTING SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 30 ON-SITE TESTING SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 31 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 32 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 33 DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 34 DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 35 ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 36 ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 37 ANALYTICAL INSTRUMENT TYPES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 38 ANALYTICAL INSTRUMENT TYPES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 39 BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 40 BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 41 BREATHALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 42 BREATHALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 43 FUEL-CELL BREATHALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 44 FUEL-CELL BREATHALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 45 SEMICONDUCTOR BREATHALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 46 SEMICONDUCTOR BREATHALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 47 OTHER BREATHALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 48 OTHER BREATHALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 49 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 50 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 51 CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 52 CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 53 ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 54 ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 55 ANALYTICAL INSTRUMENT MODALITIES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 56 ANALYTICAL INSTRUMENT MODALITIES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 57 HAND-HELD DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 58 HAND-HELD DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 59 BENCHTOP DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 60 BENCHTOP DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 61 RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 62 RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 63 RAPID TESTING DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 64 RAPID TESTING DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 65 URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 66 URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 67 URINE TESTING DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 68 URINE TESTING DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 69 DRUG TESTING CUPS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 70 DRUG TESTING CUPS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 71 DIP CARDS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 72 DIP CARDS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 73 DRUG TESTING CASSETTES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 74 DRUG TESTING CASSETTES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 75 ORAL FLUID TESTING DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 76 ORAL FLUID TESTING DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 77 CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 78 CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 79 CONSUMABLES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 80 CONSUMABLES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 81 ASSAY KITS MARKET, BY COUNTRY 2018–2022 (USD MILLION)
  • TABLE 82 ASSAY KITS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 83 SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 84 SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 85 CALIBRATORS AND CONTROLS MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 86 CALIBRATORS AND CONTROLS MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 87 OTHER CONSUMABLES MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 88 OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 89 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 90 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 91 DRUG SCREENING MARKET FOR URINE SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 92 DRUG SCREENING MARKET FOR URINE SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 93 DRUG SCREENING MARKET FOR BREATH SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 94 DRUG SCREENING MARKET FOR BREATH SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 95 DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 96 DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 97 DRUG SCREENING MARKET FOR HAIR SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 98 DRUG SCREENING MARKET FOR HAIR SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 99 DRUG SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 100 DRUG SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 101 DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 102 DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 103 DRUG SCREENING MARKET FOR CANNABIS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 104 DRUG SCREENING MARKET FOR CANNABIS, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 105 DRUG SCREENING MARKET FOR ALCOHOL, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 106 DRUG SCREENING MARKET FOR ALCOHOL, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 107 DRUG SCREENING MARKET FOR COCAINE, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 108 DRUG SCREENING MARKET FOR COCAINE, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 109 DRUG SCREENING MARKET FOR OPIOIDS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 110 DRUG SCREENING MARKET FOR OPIOIDS, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 111 DRUG SCREENING MARKET FOR AMPHETAMINE AND METHAMPHETAMINE, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 112 DRUG SCREENING MARKET FOR AMPHETAMINE AND METHAMPHETAMINE, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 113 DRUG SCREENING MARKET FOR OTHER DRUGS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 114 DRUG SCREENING MARKET FOR OTHER DRUGS, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 115 DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 116 DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 117 DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 118 DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 119 DRUG SCREENING MARKET FOR WORKPLACES, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 120 DRUG SCREENING MARKET FOR WORKPLACES, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 121 DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 122 DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 123 DRUG SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 124 DRUG SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 125 DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 126 DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 127 DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 128 DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 129 DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 130 DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 131 DRUG SCREENING MARKET FOR SCHOOLS AND COLLEGES, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 132 DRUG SCREENING MARKET FOR SCHOOLS AND COLLEGES, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 133 DRUG SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 134 DRUG SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 135 DRUG SCREENING MARKET, BY REGION, 2018–2022 (USD MILLION)
  • TABLE 136 DRUG SCREENING MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 138 NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 139 NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 140 NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 141 NORTH AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 142 NORTH AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 143 NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 144 NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 145 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 146 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 147 NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 148 NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 149 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 150 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 151 NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 152 NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 153 NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 154 NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 155 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 156 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 157 NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 158 NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 159 NORTH AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 160 NORTH AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 161 NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 162 NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 163 US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 164 US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 165 US: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 166 US: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 167 US: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 168 US: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 169 US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 170 US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 171 US: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 172 US: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 173 US: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 174 US: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 175 US: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 176 US: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 177 US: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 178 US: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 179 US: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 180 US: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 181 US: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 182 US: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 183 US: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 184 US: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 185 US: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 186 US: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 187 CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 188 CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 189 CANADA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 190 CANADA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 191 CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 192 CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 193 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 194 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 195 CANADA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 196 CANADA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 197 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 198 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 199 CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 200 CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 201 CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 202 CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 203 CANADA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 204 CANADA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 205 CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 206 CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 207 CANADA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 208 CANADA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 209 CANADA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 210 CANADA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 211 EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 212 EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 213 EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 214 EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 215 EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 216 EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 217 EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 218 EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 219 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 220 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 221 EUROPE: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 222 EUROPE: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 223 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 224 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 225 EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 226 EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 227 EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 228 EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 229 EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 230 EUROPE: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 231 EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 232 EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 233 EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 234 EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 235 EUROPE: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 236 EUROPE: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 237 GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 238 GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 239 GERMANY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 240 GERMANY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 241 GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 242 GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 243 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 244 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 245 GERMANY: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 246 GERMANY: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 247 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 248 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 249 GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 250 GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 251 GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 252 GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 253 GERMANY: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 254 GERMANY: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 255 GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 256 GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 257 GERMANY: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 258 GERMANY: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 259 GERMANY: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 260 GERMANY: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 261 FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 262 FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 263 FRANCE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 264 FRANCE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 265 FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 266 FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 267 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 268 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 269 FRANCE: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 270 FRANCE: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 271 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 272 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 273 FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 274 FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 275 FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 276 FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 277 FRANCE: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 278 FRANCE: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 279 FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 280 FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 281 FRANCE: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 282 FRANCE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 283 FRANCE: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 284 FRANCE: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 285 UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 286 UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 287 UK: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 288 UK: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 289 UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 290 UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 291 UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 292 UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 293 UK: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 294 UK: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 295 UK: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 296 UK: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 297 UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 298 UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 299 UK: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 300 UK: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 301 UK: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 302 UK: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 303 UK: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 304 UK: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 305 UK: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 306 UK: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 307 UK: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 308 UK: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 309 ITALY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 310 ITALY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 311 ITALY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 312 ITALY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 313 ITALY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 314 ITALY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 315 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 316 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 317 ITALY: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 318 ITALY: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 319 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 320 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 321 ITALY: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 322 ITALY: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 323 ITALY: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 324 ITALY: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 325 ITALY: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 326 ITALY: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 327 ITALY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 328 ITALY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 329 ITALY: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 330 ITALY: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 331 ITALY: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 332 ITALY: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 333 SPAIN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 334 SPAIN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 335 SPAIN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 336 SPAIN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 337 SPAIN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 338 SPAIN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 339 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 340 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 341 SPAIN: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 342 SPAIN: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 343 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 344 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 345 SPAIN: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 346 SPAIN: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 347 SPAIN: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 348 SPAIN: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 349 SPAIN: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 350 SPAIN: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 351 SPAIN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 352 SPAIN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 353 SPAIN: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 354 SPAIN: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 355 SPAIN: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 356 SPAIN: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 357 REST OF EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 358 REST OF EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 359 REST OF EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 360 REST OF EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 361 REST OF EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 362 REST OF EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 363 REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, 2018–2022 (USD MILLION)
  • TABLE 364 REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 365 REST OF EUROPE: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 366 REST OF EUROPE: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 367 REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 368 REST OF EUROPE ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 369 REST OF EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 370 REST OF EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 371 REST OF EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 372 REST OF EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 373 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 374 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 375 REST OF EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 376 REST OF EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 377 REST OF EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 378 REST OF EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 379 REST OF EUROPE: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 380 REST OF EUROPE: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 381 ASIA PACIFIC: DRUG SCREENING MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 382 ASIA PACIFIC: DRUG SCREENING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 383 ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 384 ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 385 ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 386 ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 387 ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 388 ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 389 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 390 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 391 ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 392 ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 393 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 394 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 395 ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 396 ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 397 ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 398 ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 399 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 400 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 401 ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 402 ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 403 ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 404 ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 405 ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 406 ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 407 JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 408 JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 409 JAPAN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 410 JAPAN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 411 JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 412 JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 413 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 414 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 415 JAPAN: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 416 JAPAN: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 417 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 418 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 419 JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 420 JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 421 JAPAN: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 422 JAPAN: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 423 JAPAN: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 424 JAPAN: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 425 JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 426 JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 427 JAPAN: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 428 JAPAN: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 429 JAPAN: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 430 JAPAN: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 431 CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 432 CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 433 CHINA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 434 CHINA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 435 CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 436 CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 437 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 438 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 439 CHINA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 440 CHINA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 441 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 442 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 443 CHINA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 444 CHINA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 445 CHINA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 446 CHINA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 447 CHINA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 448 CHINA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 449 CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 450 CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 451 CHINA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 452 CHINA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 453 CHINA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 454 CHINA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 455 INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 456 INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 457 INDIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 458 INDIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 459 INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 460 INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 461 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 462 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 463 INDIA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 464 INDIA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 465 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 466 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 467 INDIA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 468 INDIA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 469 INDIA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 470 INDIA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 471 INDIA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 472 INDIA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 473 INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 474 INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 475 INDIA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 476 INDIA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 477 INDIA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 478 INDIA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 479 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 480 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 481 REST OF ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 482 REST OF ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 483 REST OF ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 484 REST OF ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 485 REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 486 REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 487 REST OF ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 488 REST OF ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 489 REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 490 REST OF ASIA PACIFIC ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 491 REST OF ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 492 REST OF ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 493 REST OF ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 494 REST OF ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 495 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 496 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 497 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 498 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 499 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 500 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 501 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 502 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 503 LATIN AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2018–2022 (USD MILLION)
  • TABLE 504 LATIN AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2023–2029 (USD MILLION)
  • TABLE 505 LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 506 LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 507 LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 508 LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 509 LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 510 LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 511 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 512 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 513 LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 514 LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 515 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 516 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 517 LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 518 LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 519 LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 520 LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 521 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 522 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 523 LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 524 LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 525 LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 526 LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 527 LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 528 LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 529 BRAZIL: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 530 BRAZIL: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 531 BRAZIL: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 532 BRAZIL: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 533 BRAZIL: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 534 BRAZIL: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 535 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 536 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 537 BRAZIL: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 538 BRAZIL: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 539 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 540 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 541 BRAZIL: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 542 BRAZIL: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 543 BRAZIL: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 544 BRAZIL: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 545 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 546 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 547 BRAZIL: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 548 BRAZIL: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 549 BRAZIL: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 550 BRAZIL: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 551 BRAZIL: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 552 BRAZIL: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 553 MEXICO: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 554 MEXICO: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 555 MEXICO: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 556 MEXICO: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 557 MEXICO: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 558 MEXICO: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 559 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 560 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 561 MEXICO: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 562 MEXICO: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 563 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 564 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 565 MEXICO: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 566 MEXICO: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 567 MEXICO: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 568 MEXICO: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 569 MEXICO: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 570 MEXICO: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 571 MEXICO: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 572 MEXICO: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 573 MEXICO: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 574 MEXICO: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 575 MEXICO: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 576 MEXICO: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 577 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 578 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 579 REST OF LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 580 REST OF LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 581 REST OF LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 582 REST OF LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 583 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 584 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 585 REST OF LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 586 REST OF LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 587 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 588 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 589 REST OF LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 590 REST OF LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 591 REST OF LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 592 REST OF LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 593 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 594 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 595 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 596 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 597 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 598 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 599 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 600 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 601 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY REGION, 2018–2022 (USD MILLION)
  • TABLE 602 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY REGION, 2023–2029 (USD MILLION)
  • TABLE 603 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 604 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 605 MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 606 MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 607 MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 608 MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 609 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 610 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 611 MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 612 MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 613 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 614 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 615 MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 616 MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 617 MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 618 MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 619 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 620 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 621 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 622 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 623 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 624 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 625 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 626 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 627 GCC COUNTRIES: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 628 GCC COUNTRIES: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 629 GCC COUNTRIES: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 630 GCC COUNTRIES: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 631 GCC COUNTRIES: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 632 GCC COUNTRIES: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 633 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 634 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 635 GCC COUNTRIES: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 636 GCC COUNTRIES: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 637 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 638 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 639 GCC COUNTRIES: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 640 GCC COUNTRIES: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 641 GCC COUNTRIES: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 642 GCC COUNTRIES: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 643 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 644 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 645 GCC COUNTRIES: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 646 GCC COUNTRIES: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 647 GCC COUNTRIES: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 648 GCC COUNTRIES: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 649 GCC COUNTRIES: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 650 GCC COUNTRIES: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 651 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2022 (USD MILLION)
  • TABLE 652 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023–2029 (USD MILLION)
  • TABLE 653 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 654 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 655 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 656 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 657 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 658 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 659 REST OF MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 660 REST OF MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 661 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018–2022 (USD MILLION)
  • TABLE 662 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023–2029 (USD MILLION)
  • TABLE 663 REST OF MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 664 REST OF MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 665 REST OF MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 666 REST OF MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 667 REST OF MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2018–2022 (USD MILLION)
  • TABLE 668 REST OF MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2023–2029 (USD MILLION)
  • TABLE 669 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2022 (USD MILLION)
  • TABLE 670 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023–2029 (USD MILLION)
  • TABLE 671 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018–2022 (USD MILLION)
  • TABLE 672 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023–2029 (USD MILLION)
  • TABLE 673 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2018–2022 (USD MILLION)
  • TABLE 674 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2023–2029 (USD MILLION)
  • TABLE 675 DRUG SCREENING MARKET: DEGREE OF COMPETITION
  • TABLE 676 DRUG SCREENING MARKET: OVERALL FOOTPRINT
  • TABLE 677 DRUG SCREENING MARKET: PRODUCT FOOTPRINT
  • TABLE 678 DRUG SCREENING MARKET: SERVICE FOOTPRINT
  • TABLE 679 DRUG SCREENING MARKET: SAMPLE TYPE FOOTPRINT
  • TABLE 680 DRUG SCREENING MARKET: DRUG TYPE FOOTPRINT
  • TABLE 681 DRUG SCREENING MARKET: REGIONAL FOOTPRINT
  • TABLE 682 DRUG SCREENING MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 683 DRUG SCREENING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • TABLE 684 DRUG SCREENING MARKET: PRODUCT/SERVICE LAUNCHES AND DEVELOPMENTS, JANUARY 2021–APRIL 2024
  • TABLE 685 DRUG SCREENING MARKET: DEALS, JANUARY 2021–APRIL 2024
  • TABLE 686 DRUG SCREENING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2024
  • TABLE 687 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
  • TABLE 688 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 689 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS
  • TABLE 690 QUEST DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 691 QUEST DIAGNOSTICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 692 QUEST DIAGNOSTICS: SERVICE LAUNCHES
  • TABLE 693 QUEST DIAGNOSTICS: DEALS
  • TABLE 694 ABBOTT: COMPANY OVERVIEW
  • TABLE 695 ABBOTT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 696 ORASURE TECHNOLOGIES INC.: COMPANY OVERVIEW
  • TABLE 697 ORASURE TECHNOLOGIES INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 698 ORASURE TECHNOLOGIES INC.: DEALS
  • TABLE 699 ALFA SCIENTIFIC DESIGNS INC.: COMPANY OVERVIEW
  • TABLE 700 ALFA SCIENTIFIC DESIGNS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 701 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 702 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 703 THERMO FISHER SCIENTIFIC INC.: PRODUCT DEVELOPMENTS
  • TABLE 704 THERMO FISHER SCIENTIFIC INC.: DEALS
  • TABLE 705 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW
  • TABLE 706 DRÄGERWERK AG & CO. KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 707 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES AND APPROVALS
  • TABLE 708 LIFELOC TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 709 LIFELOC TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 710 MPD INC.: COMPANY OVERVIEW
  • TABLE 711 MPD INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 712 OMEGA LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 713 OMEGA LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 714 OMEGA LABORATORIES, INC.: SERVICE LAUNCHES
  • TABLE 715 OMEGA LABORATORIES, INC.: DEALS
  • TABLE 716 OMEGA LABORATORIES, INC.: OTHER DEVELOPMENTS
  • TABLE 717 PREMIER BIOTECH, INC.: COMPANY OVERVIEW
  • TABLE 718 PREMIER BIOTECH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 719 PSYCHEMEDICS CORPORATION: COMPANY OVERVIEW
  • TABLE 720 PSYCHEMEDICS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 721 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 722 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 723 SHIMADZU CORPORATION: COMPANY OVERVIEW
  • TABLE 724 SHIMADZU CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 725 SHIMADZU CORPORATION: PRODUCT LAUNCHES
  • TABLE 726 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 727 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 728 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES
  • TABLE 729 SIEMENS HEALTHINEERS AG: DEALS
  • TABLE 730 AMERICAN BIO MEDICA CORPORATION: COMPANY OVERVIEW
  • TABLE 731 ACM GLOBAL LABORATORIES: COMPANY OVERVIEW
  • TABLE 732 CAREHEALTH AMERICA CORP.: COMPANY OVERVIEW
  • TABLE 733 CLINICAL REFERENCE LABORATORY, INC.: COMPANY OVERVIEW
  • TABLE 734 INTOXIMETERS: COMPANY OVERVIEW
  • TABLE 735 SCITECK, INC.: COMPANY OVERVIEW
  • TABLE 736 ACCUSOURCEHR, INC.: COMPANY OVERVIEW
  • TABLE 737 CORDANT HEALTH SOLUTIONS: COMPANY OVERVIEW
  • TABLE 738 INTOXALOCK: COMPANY OVERVIEW
  • TABLE 739 MILLENNIUM HEALTH: COMPANY OVERVIEW
  • TABLE 740 ADVACARE PHARMA: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 DRUG SCREENING MARKET: MARKETS COVERED
  • FIGURE 2 DRUG SCREENING MARKET: REGIONS COVERED
  • FIGURE 3 DRUG SCREENING MARKET: RESEARCH DESIGN
  • FIGURE 4 DRUG SCREENING MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 DRUG SCREENING MARKET: PRIMARY SOURCES
  • FIGURE 6 DRUG SCREENING MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 DRUG SCREENING MARKET: KEY INDUSTRY INSIGHTS
  • FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY, DESIGNATION, AND REGION
  • FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
  • FIGURE 10 MARKET SIZE ESTIMATION (SUPPLY SIDE): REVENUE SHARE ANALYSIS
  • FIGURE 11 DRUG SCREENING MARKET: BOTTOM-UP APPROACH
  • FIGURE 12 DRUG SCREENING MARKET: TOP-DOWN APPROACH
  • FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029)
  • FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 15 DATA TRIANGULATION METHODOLOGY
  • FIGURE 16 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 DRUG SCREENING MARKET, BY DRUG TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 19 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 20 DRUG SCREENING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 21 REGIONAL SEGMENTATION OF DRUG SCREENING MARKET
  • FIGURE 22 GROWING CONSUMPTION OF ILLICIT DRUGS AND ALCOHOL TO DRIVE MARKET
  • FIGURE 23 US AND DRUG SCREENING SERVICES TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD
  • FIGURE 24 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING STUDY PERIOD
  • FIGURE 25 INDIA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 27 DRUG SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 28 SHIFTS AND NEW REVENUE POCKETS FOR DRUG SCREENING MARKET
  • FIGURE 29 DRUG SCREENING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 DRUG SCREENING MARKET: ECOSYSTEM MAP
  • FIGURE 31 DRUG SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 34 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
  • FIGURE 35 PATENT PUBLICATION TRENDS IN DRUG SCREENING MARKET (JANUARY 2012–DECEMBER 2023)
  • FIGURE 36 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DRUG SCREENING PATENTS (JANUARY 2012–NOVEMBER 2023)
  • FIGURE 37 TOP APPLICANT COUNTRIES/REGIONS FOR DRUG SCREENING PATENTS (JANUARY 2012–DECEMBER 2023)
  • FIGURE 38 FUNDING OF KEY PLAYERS IN DRUG SCREENING MARKET
  • FIGURE 39 IMPORT DATA FOR CHROMATOGRAPHY (HS CODE 902720), BY COUNTRY, 2019–2023 (USD)
  • FIGURE 40 EXPORT DATA FOR CHROMATOGRAPHY (HS CODE 902720), BY COUNTRY, 2019–2023 (USD MILLION)
  • FIGURE 41 NORTH AMERICA: DRUG SCREENING MARKET SNAPSHOT
  • FIGURE 42 ASIA PACIFIC: DRUG SCREENING MARKET SNAPSHOT
  • FIGURE 43 DRUG SCREENING MARKET: STRATEGIES ADOPTED
  • FIGURE 44 DRUG SCREENING MARKET: REVENUE ANALYSIS (2019–2023)
  • FIGURE 45 DRUG SCREENING MARKET: MARKET SHARE ANALYSIS (2023)
  • FIGURE 46 DRUG SCREENING MARKET RANKING, BY KEY PLAYER (2023)
  • FIGURE 47 DRUG SCREENING MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 48 DRUG SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 49 DRUG SCREENING MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  • FIGURE 50 EV/EBITDA OF KEY VENDORS
  • FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 52 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2023)
  • FIGURE 53 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2023)
  • FIGURE 54 ABBOTT: COMPANY SNAPSHOT (2023)
  • FIGURE 55 ORASURE TECHNOLOGIES INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 56 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 57 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 58 LIFELOC TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 59 PSYCHEMEDICS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 60 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 61 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 62 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)

This study involved four major activities in estimating the current size of the drug screening market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the drug screening market. The researchers used secondary sources, which means they looked at existing information instead of collecting new data themselves. These secondary sources included reports and publications from organizations like the World Health Organization (WHO) and the National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism (NIAAA), Substance Abuse and Mental Health Services Administration (SAMHSA), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Asia-Pacific Society for Alcohol and Addiction Research (APSAAR), National Institute on Drug Abuse (NIDA), Federation of Indian NGOs for Drugs and AIDS Prevention (FINGODAP), International Journal of Drug Policy, American Journal of Drug and Alcohol Abuse, Annual Reports, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. This method allowed the researchers to gather information on the market size, segmentation (by product type, customer, etc.), regional analysis, future trends, and technological advancements in the drug screening market.

Primary Research

In-depth interviews were conducted with various primary respondents, researchers conducted in-depth interviews with a variety of people. They talked to important people in the industry, like CEOs of major companies that make drug screening products or provide drug screening services. They also spoke with specialists who know a lot about this market, and consultants who advise businesses on how to make money in this field.

Breakdown of the primary respondents:

Drug Screening Market Size, and Share

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product and service managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the drug screening market as well as to estimate the market size of various other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research.
  • The revenues generated from the drug screening business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Bottom-Up Approach: No of Testing Volume Based Estimation:

Drug Screening Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Drug Screening Market: Top-Down Approach

Drug Screening Market Size, and Share

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Drug & alcohol testing or drug screening refers to testing individuals for illegal abuse of drugs (including legal drugs such as prescription drugs) through the use of biological samples, such as urine, oral fluids/saliva, hair, blood, and sweat.

Key stakeholders:

  • Drug and alcohol testing laboratories
  • Drug and alcohol testing product manufacturers
  • Rapid drug screening device manufacturers
  • Law enforcement agencies
  • Healthcare providers
  • Government agencies
  • Research and consulting firms
  • Venture capitalists

Report Objectives

  • To define, describe, and forecast the global drug screening market based on the product and service, sample type, drug type, end user and region.
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall drug screening market.
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
  • To track and analyze competitive developments such as acquisitions, product and services launches, approvals, expansions, agreements, partnerships, and R&D activities in the drug screening market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Company Information

  • An additional five company profiles

Previous Versions of this Report

Drug Screening Market by Product (Consumables, Urine Testing Devices, Analytical, Breathalyzer, Chromatography, Immunoassay) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) - Global Forecast to 2026

Report Code MD 3239
Published in Jan, 2022, By MarketsandMarkets™

Drug Screening Market by Product (Consumables, Urine testing devices, Analytical, Breathalyzer, Chromatography) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) - Global Forecast to 2025

Report Code MD 3239
Published in Dec, 2020, By MarketsandMarkets™

Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2022

Report Code MD 3239
Published in Jan, 2018, By MarketsandMarkets™

Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2022

Report Code MD 3239
Published in Mar, 2015, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Drug Screening Market

DMCA.com Protection Status